SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-176877
Filing Date
2023-06-28
Accepted
2023-06-28 08:37:28
Documents
16
Period of Report
2023-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d527050d8k.htm   iXBRL 8-K 33910
2 EX-4.1 d527050dex41.htm EX-4.1 65222
3 EX-10.1 d527050dex101.htm EX-10.1 179534
4 EX-99.1 d527050dex991.htm EX-99.1 8353
8 GRAPHIC g527050g0627074225901.jpg GRAPHIC 2957
  Complete submission text file 0001193125-23-176877.txt   480531

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nerv-20230627.xsd EX-101.SCH 2877
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20230627_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20230627_pre.xml EX-101.PRE 10830
10 EXTRACTED XBRL INSTANCE DOCUMENT d527050d8k_htm.xml XML 3285
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 231049388
SIC: 2834 Pharmaceutical Preparations